Role of Lutein Supplementation in the Management of Age-Related Macular Degeneration: Meta-Analysis of Randomized Controlled Trials

@article{Wang2014RoleOL,
  title={Role of Lutein Supplementation in the Management of Age-Related Macular Degeneration: Meta-Analysis of Randomized Controlled Trials},
  author={Xin Wang and Cai-hui Jiang and Ying Zhang and Yan Gong and Xiaofei Chen and Mao‐nian Zhang},
  journal={Ophthalmic Research},
  year={2014},
  volume={52},
  pages={198 - 205}
}
Objective: The conduct of this meta-analysis aimed at examining the individual role of lutein as a dietary supplement in improving conditions of age-related macular degeneration (AMD) from the data generated from randomized controlled trials (RCTs). Method: The literature search was made in multiple electronic databases. Eligibility criteria were RCTs that recruited AMD patients or individuals at risk and evaluated lutein supplementation efficacy against placebo. The quality of the trials was… 

Figures and Tables from this paper

The level and efficacy of lutein in patients with age-related macular degeneration: a comprehensive systematic review and meta-analysis

Although current evidence does not support circulating lutein as a biomarker for early screening of the high-risk AMD population, it is reasonable to give the current analysis result that high dose (20 mg/d) and long duration (>6 months) of luteIn intake could be beneficial to AMD patients.

Effects of lutein supplementation in age-related macular degeneration

Meta-analysis suggested that lutein supplementation (10 or 20 mg per day) was associated with an increase in MPOD and the higher dose could make MPOD increase in a shorter time.

Appraising the Quality of Systematic Reviews for Age-Related Macular Degeneration Interventions: A Systematic Review

There was poor adherence to referring to an a priori design and reporting conflicts of interest in both the review and included studies, and reviews funded by government grants and/or institutions were generally of higher quality than industry-sponsored reviews or where the funding source was not reported.

Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.

A systematic review of treatments for dry AMD and STGD was carried out, and a number of promising research topics were identified, including drug treatments, stem cells, new forms of laser treatment, and implantable intraocular lens telescopes.

Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial

Daily consumption of a dairy drink containing lutein-enriched egg yolks for one year improves visual acuity, MPOD, and plasma lute in concentration in elderly subjects with drusen and/or retinal pigment epithelial abnormalities.

Effects of 12-week avocado consumption on cognitive function among adults with overweight and obesity.

  • C. EdwardsA. Walk N. Khan
  • Medicine
    International journal of psychophysiology : official journal of the International Organization of Psychophysiology
  • 2019

The Effect of Lutein on Eye and Extra-Eye Health

Based on the most recent findings, a review will focus on lutein properties, dietary sources, usual intake, efficacy in human health, and toxicity.

A Critical Appraisal of National and International Clinical Practice Guidelines Reporting Nutritional Recommendations for Age-Related Macular Degeneration: Are Recommendations Evidence-Based?

There is significant scope for improving current Clinical Practice Guidelines for AMD, and guideline developers should use evidence from existing high quality systematic reviews to inform clinical recommendations.

An Overview on the Role of Macular Xanthophylls in Ocular Diseases

The relationship between the consumption of lutein and zeaxanthin and eye diseases and other ocular disorders such as cataract, glaucoma and choroideremia is evaluated.

Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration

Baseline serum MDA levels were elevated in patients with wet age-related macular degeneration, and MDA Levels were directly correlated with choroidal neovascularization lesion area, and nutritional supplementation appeared to exert a protective effect against oxidative stress in Patients with wAMD.

References

SHOWING 1-10 OF 50 REFERENCES

Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.

It is demonstrated that lutein supplementation increases macular pigment optical density, as assessed with an objective study, and indicates that patients who show a pronounced increase in MPOD also benefit in terms of visual function.

Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.

L supplementation increases MPOD levels in early stage AMD patients, and according to the VA measurements, the progress of the disease might be slowed in some patients with augmented levels of MP.

Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis

Dietary lutein and zeaxanthin is not significantly associated with a reduced risk of early AMD, whereas an increase in the intake of these carotenoids may be protective against late AMD, however, additional studies are needed to confirm these relationships.

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

The totality of evidence on beneficial and adverse effects from AREDS2 and other studies suggests that lutein/zeaxanthin could be more appropriate than beta carotene in the AREDs-type supplements.

Serum antioxidants and age-related macular degeneration in a population-based case-control study.

Very low levels of one (lycopene) but not other dietary carotenoids or tocopherols were related to ARMD, and lower levels of vitamin E in subjects with exudative macular degeneration compared with controls may be explained by higher levels of serum lipids.

Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.

Diets rich in lutein plus zeaxanthin may protect against intermediate AMD in healthy women younger than 75 years with a history of chronic diseases that are often associated with diet changes.